A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy

International Forum of Allergy and Rhinology

Volumn 2, Issue 4, 2012, Pages 280-284

  Hsu, Nicole M ^a   Reisacher, William R ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Adherence; Allergic rhinitis; Duration; Efficacy; Immunotherapy; Noncompliance

Indexed keywords

ALLERGEN;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CHILD; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HEART PALPITATION; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; SCHOOL CHILD; SIDE EFFECT; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; TREATMENT REFUSAL; TREATMENT WITHDRAWAL; URTICARIA;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DROPOUTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864815328     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21037     Document Type: Article

References (12)

1. Frew AJ. Immunotherapy of allergic disease. J Allergy Clin Immunol. 2003;111(2 Suppl):S712-S719.
2. Incorvaia C, Mauro M, Ridolo E, et al. Patient's compliance with allergen immunotherapy. Patient Prefer Adherence. 2008;2:247-251.
3. Pokladnikova J, Krcmova I, Vlcek J. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol. 2008;100:482-489.
4. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol. 1999;82:281-286.
5. Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year). J Allergy Clin Immunol. 2006;117:946-948.
6. Köberlein J, Kothe AC, Schaffert C. Determinants of patient compliance in allergic rhinoconjunctivitis. Curr Opin Allergy Clin Immunol. 2011;11:192-199.
7. Blackwell B. Drug therapy: patient compliance. N Engl J Med. 1973;289:249-252.
8. Incorvaia C, Masieri S, Scurati S, et al. The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children. J Asthma Allergy. 2011;4:13-17.
9. Lombardi C, Gani F, Landi M, et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol. 2004;113:1219-1220.
10. Sade K, Berkun Y, Dolev Z, et al. Knowledge and expectations of patients receiving aeroallergen immunotherapy. Ann Allergy Asthma Immunol. 2003;91:444-448.
11. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol. 1993;91:734-737.
12. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol. 2002;88:391-394.